 |
|
Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
Keun-Sik Hong
J Stroke. 2019;21(3):259-275. Published online 2019 Sep 30 DOI: https://doi.org/10.5853/jos.2019.01970
|
|
Citations to this article as recorded by
 Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical Evidence
Adrija Hajra, Aditi Ujjawal, Natasha Ghalib, Selia Chowdhury, Suman Biswas, Prasanth Balasubramanian, Rahul Gupta, Wilbert S Aronow
Current Problems in Cardiology.2024; 49(1): 102017. CrossRef Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review
Tomasz Górnicki, Kacper Bułdyś, Dorota Zielińska, Mariusz Chabowski
Cancers.2023; 15(10): 2697. CrossRef Use of Non-Vitamin K Dependent Oral Anticoagulant in Ischemic Stroke
Hyungjong Park, Joonsang Yoo
Journal of the Korean Neurological Association.2022; 40(1): 1. CrossRef Risk for Venous Thromboembolic Events in Patients With Advanced Urinary Tract Cancer Treated With First-Line Chemotherapy
Aristotelis Bamias, Kimon Tzannis, Ioannis Dimitriadis, Georgios Tsironis, Alkistis-Maria Papatheorodidi, Anna Tsiara, Charalampos Fragkoulis, Aikaterini Xirokosta, Despoina Barbarousi, Georgios Papadopoulos, Roubini Zakopoulou, Ioannis Varkarakis, Irakli
Clinical Genitourinary Cancer.2020;[Epub] CrossRef A case-report of two patients with hereditary protein S deficiency treated by rivaroxaban
Jianyao Lou, Li Yin, Xueying Ke, Liang Zhang, Fangfang Xu, Zhenjie Liu
Blood Coagulation & Fibrinolysis.2020; 31(6): 405. CrossRef Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?
Jong S. Kim
Journal of Stroke.2019; 21(3): 241. CrossRef
|